TCTMD talked to Dr. Mikhail Kosiborod about the DEFINE-HF and PRESERVED-HF trials presented at the European Society of Cardiology Heart Failure Congress.
Healthcare Executive talked to Julie Quirin, Chief Operating Officer and Senior Vice President of Saint Luke's Health System, about how Saint Luke's is strategically planning for the future.
Dapagliflozin improves symptoms and physical limitations in people with heart failure across the spectrum of ejection fractions, according to a pooled analysis of the DEFINE-HF and PRESERVED-HF trials.
